New diagnostic tool for Hypoactive Sexual Desire Disorder (HSDD) in women
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
Pfizer Expands Portfolio of Generic Medicines in the U.S. and Europe
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
AstraZeneca and MAP Pharmaceuticals, Inc. Announce Worldwide Collaboration
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Advances in Renal Cancer Journalists' Award
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Novartis shareholders approved 25% dividend increase
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
Pfizer Discontinues Development of Two Phase 3 Compounds
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
More Pharma News ...
- Nycomed reports a satisfactory 2008
- Schering-Plough announces collaboration with World Health Organization
- Encouraging results support further development of Almirall's long-acting beta-agonist (LABA)
- Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
- The safety of patients is of utmost importance to Merck
- GSK initiates phase III programme for novel type 2 diabetes medication, Syncria® (albiglutide)
- FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab